| pubmed-article:11895273 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11895273 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11895273 | lifeskim:mentions | umls-concept:C0038586 | lld:lifeskim |
| pubmed-article:11895273 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
| pubmed-article:11895273 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:11895273 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:11895273 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11895273 | pubmed:dateCreated | 2002-3-15 | lld:pubmed |
| pubmed-article:11895273 | pubmed:abstractText | The purpose of this study was to develop an index of risk factors to identify patients prospectively with substance use disorders whose substance use symptoms exacerbate during or shortly after treatment, and to identify characteristics of care that may reduce the likelihood of exacerbation. | lld:pubmed |
| pubmed-article:11895273 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11895273 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11895273 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11895273 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11895273 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11895273 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11895273 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11895273 | pubmed:issn | 0965-2140 | lld:pubmed |
| pubmed-article:11895273 | pubmed:author | pubmed-author:MoosRudolf... | lld:pubmed |
| pubmed-article:11895273 | pubmed:author | pubmed-author:NicholAran... | lld:pubmed |
| pubmed-article:11895273 | pubmed:author | pubmed-author:MoosBernice... | lld:pubmed |
| pubmed-article:11895273 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11895273 | pubmed:volume | 97 | lld:pubmed |
| pubmed-article:11895273 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11895273 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11895273 | pubmed:pagination | 75-85 | lld:pubmed |
| pubmed-article:11895273 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:meshHeading | pubmed-meshheading:11895273... | lld:pubmed |
| pubmed-article:11895273 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11895273 | pubmed:articleTitle | Risk factors for symptom exacerbation among treated patients with substance use disorders. | lld:pubmed |
| pubmed-article:11895273 | pubmed:affiliation | Center For Health Care Evaluation, VA Health Care System, Menlo Park, CA 94025, USA. bmoos@stanford.edu | lld:pubmed |
| pubmed-article:11895273 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11895273 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11895273 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11895273 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11895273 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11895273 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11895273 | lld:pubmed |
